These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 10078716)
1. Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Marder K; Tang MX; Alfaro B; Mejia H; Cote L; Louis E; Stern Y; Mayeux R Neurology; 1999 Mar; 52(4):719-24. PubMed ID: 10078716 [TBL] [Abstract][Full Text] [Related]
2. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614 [TBL] [Abstract][Full Text] [Related]
3. Lack of familial aggregation of Parkinson disease and Alzheimer disease. Levy G; Louis ED; Mejia-Santana H; Côté L; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Ottman R; Marder K Arch Neurol; 2004 Jul; 61(7):1033-9. PubMed ID: 15262733 [TBL] [Abstract][Full Text] [Related]
4. Influence of APOE genotype on familial aggregation of AD in an urban population. Devi G; Ottman R; Tang M; Marder K; Stern Y; Tycko B; Mayeux R Neurology; 1999 Sep; 53(4):789-94. PubMed ID: 10489042 [TBL] [Abstract][Full Text] [Related]
5. Risk of Parkinson's disease among first-degree relatives: A community-based study. Marder K; Tang MX; Mejia H; Alfaro B; Côté L; Louis E; Groves J; Mayeux R Neurology; 1996 Jul; 47(1):155-60. PubMed ID: 8710070 [TBL] [Abstract][Full Text] [Related]
6. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Marder K; Maestre G; Cote L; Mejia H; Alfaro B; Halim A; Tang M; Tycko B; Mayeux R Neurology; 1994 Jul; 44(7):1330-1. PubMed ID: 8035940 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease. Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010 [TBL] [Abstract][Full Text] [Related]
8. Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease. Heun R; Ptok U; Kölsch H; Maier W; Jessen F Dement Geriatr Cogn Disord; 2004; 18(2):151-8. PubMed ID: 15211070 [TBL] [Abstract][Full Text] [Related]
9. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850 [TBL] [Abstract][Full Text] [Related]
10. Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study. Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K Mov Disord; 2002 Mar; 17(2):250-7. PubMed ID: 11921109 [TBL] [Abstract][Full Text] [Related]
11. Risk of dementia among white and African American relatives of patients with Alzheimer disease. Green RC; Cupples LA; Go R; Benke KS; Edeki T; Griffith PA; Williams M; Hipps Y; Graff-Radford N; Bachman D; Farrer LA; JAMA; 2002 Jan; 287(3):329-36. PubMed ID: 11790212 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953 [TBL] [Abstract][Full Text] [Related]
13. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Silverman JM; Raiford K; Edland S; Fillenbaum G; Morris JC; Clark CM; Kukull W; Heyman A Neurology; 1994 Jul; 44(7):1253-9. PubMed ID: 8035925 [TBL] [Abstract][Full Text] [Related]
14. Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease. Mickel SF; Broste SK; Hiner BC Neurology; 1997 Apr; 48(4):942-9. PubMed ID: 9109882 [TBL] [Abstract][Full Text] [Related]
15. Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Farrer LA; O'Sullivan DM; Cupples LA; Growdon JH; Myers RH Ann Neurol; 1989 May; 25(5):485-93. PubMed ID: 2774490 [TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872 [TBL] [Abstract][Full Text] [Related]
18. Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. Mayeux R; Sano M; Chen J; Tatemichi T; Stern Y Arch Neurol; 1991 Mar; 48(3):269-73. PubMed ID: 2001183 [TBL] [Abstract][Full Text] [Related]
19. Head injury and the risk of AD in the MIRAGE study. Guo Z; Cupples LA; Kurz A; Auerbach SH; Volicer L; Chui H; Green RC; Sadovnick AD; Duara R; DeCarli C; Johnson K; Go RC; Growdon JH; Haines JL; Kukull WA; Farrer LA Neurology; 2000 Mar; 54(6):1316-23. PubMed ID: 10746604 [TBL] [Abstract][Full Text] [Related]
20. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia. Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]